NLRP3 Inflammasome May Be a Biomarker for Risk Stratification in Patients with Acute Coronary Syndrome
De-Gang Mo,1 Lin Wang,2 Qian-Feng Han,1 Kang Yu,3 Jia-Hui Liu,1 Heng-Chen Yao1 1Department of Cardiology, Liaocheng People’s Hospital Affiliated to Shandong First Medical University, Liaocheng, People’s Republic of China; 2Cardiologic Color Doppler Room, Liaocheng People’s Hospital Affiliated to Sha...
Main Authors: | Mo DG, Wang L, Han QF, Yu K, Liu JH, Yao HC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-12-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/nlrp3-inflammasome-may-be-a-biomarker-for-risk-stratification-in-patie-peer-reviewed-fulltext-article-JIR |
Similar Items
-
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
by: Geena Paramel Varghese, et al.
Published: (2016-05-01) -
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction
by: Helison R. P. Carmo, et al.
Published: (2024-01-01) -
NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction
by: Max J. M. Silvis, et al.
Published: (2022-11-01) -
Risk Stratification of Patients with Acute Coronary Syndrome
by: Dávid Bauer, et al.
Published: (2021-10-01) -
Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
by: Vibeke Bratseth, et al.
Published: (2022-09-01)